May 2 |
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 1 |
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
|
May 1 |
GSK raises profit guidance as vaccine demand grows
|
May 1 |
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
|
May 1 |
Trending tickers: Amazon, AMD, GSK and Aston Martin
|
May 1 |
GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwards
|
May 1 |
GSK Lifts Guidance After Turnover Beats Expectations
|
Apr 30 |
Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
|
Apr 30 |
Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
|
Apr 30 |
GSK Q1 2024 Earnings Preview
|